Alnylam Pharmaceuticals
ALNY
#728
Rank
โ‚น3.281 T
Marketcap
โ‚น24,526
Share price
2.55%
Change (1 day)
-38.45%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company